CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 166 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $136,000 | +72.2% | 25,664 | -3.1% | 0.00% | +100.0% |
| Q3 2020 | $79,000 | +97.5% | 26,496 | +156.3% | 0.00% | – |
| Q2 2019 | $40,000 | -68.3% | 10,336 | -58.1% | 0.00% | -100.0% |
| Q1 2019 | $126,000 | +21.2% | 24,645 | -7.6% | 0.00% | -66.7% |
| Q4 2017 | $104,000 | +258.6% | 26,658 | +132.2% | 0.00% | 0.0% |
| Q3 2017 | $29,000 | +16.0% | 11,480 | -10.8% | 0.00% | -40.0% |
| Q1 2017 | $25,000 | +108.3% | 12,863 | +10.9% | 0.01% | +25.0% |
| Q4 2016 | $12,000 | – | 11,603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 213,609 | $1,446,000 | 2.75% |
| GABLES CAPITAL MANAGEMENT INC. | 449,164 | $3,041,000 | 1.81% |
| Prairiewood Capital, LLC | 261,403 | $1,770,000 | 1.40% |
| ARMISTICE CAPITAL, LLC | 9,572,000 | $64,802,000 | 1.06% |
| Quantedge Capital Pte Ltd | 360,100 | $2,438,000 | 1.03% |
| SummerHaven Investment Management, LLC | 151,384 | $1,025,000 | 0.55% |
| GLOBEFLEX CAPITAL L P | 609,030 | $4,124,000 | 0.42% |
| EAM Global Investors LLC | 347,899 | $2,355,000 | 0.42% |
| Lanham O'Dell & Company, Inc. | 50,000 | $339,000 | 0.27% |
| EAM Investors, LLC | 239,071 | $1,619,000 | 0.27% |